Angiotensin II (Ang-II)-induced
hypertension is associated with accelerated
thrombus formation in arterioles and leukocyte recruitment in venules. The mechanisms that underlie the prothrombotic and proinflammatory responses to chronic Ang-II administration remain poorly understood. We evaluated the role of CD40/
CD40 ligand (
CD40L) signaling in Ang-II-mediated microvascular responses and assessed whether and how soluble
CD40L (sCD40L) contributes to this response. Intravital video microscopy was performed to analyze leukocyte recruitment and dihydrorhodamine-123 oxidation in postcapillary venules.
Thrombus formation in cremaster muscle arterioles was induced by using the light/
dye endothelial cell injury model. Wild-type (WT), CD40-/-, and
CD40L-/- mice received Ang-II for 14 d via osmotic minipumps. Some mice were treated with either recombinant sCD40L or the VLA5 (very late
antigen 5; α5β1) antagonist,
ATN-161. Our results demonstrate that CD40-/-,
CD40L-/-, and WT mice that were treated with
ATN-161 were protected against the thrombotic and inflammatory effects of Ang-II infusion. Infusion of sCD40L into CD40-/- or
CD40L-/- mice restored the prothrombotic effect of Ang-II infusion. Mice that were treated with
ATN-161 and infused with sCD40L were protected against accelerated
thrombosis. Collectively, these novel findings suggest that the mechanisms that underlie Ang-II-dependent thrombotic and inflammatory responses link to the signaling of
CD40L via both CD40 and VLA5.-Senchenkova, E. Y., Russell, J., Vital, S. A., Yildirim, A., Orr, A. W., Granger, D. N., Gavins, F. N. E. A critical role for both CD40 and VLA5 in
angiotensin II-mediated
thrombosis and
inflammation.